Clinical Trials Directory

Trials / Completed

CompletedNCT01896154

Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity

A Randomized, Controlled Clinical Study on the Effect of Non-digestible Polysaccharides (NPS) on the Immune Response to Influenza Vaccination in Elderly

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
239 (actual)
Sponsor
Clinical Research Center Kiel GmbH · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to estimate the effect size of a 5-week consumption period of different dietary non-digestible polysaccharides (NPS) on antibody response to influenza vaccination and cellular immunity of healthy volunteers (aged ≥ 50) for clarifying whether these NPS may enable enhancement of immune defence and to estimate the sample size for a confirmative trial. Furthermore the effects on faecal microbiota and its metabolites will be investigated.

Detailed description

The study is conducted in the frame of the collaborative project 'FibeBiotics' (Nr. 289517) (Fibers as support of the Gut and Immune function of Elderly - From polysaccharide compound to health claim) within the Seventh Framework Programme (FP7) for Research and Technological Development of the European Union (EU).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNPSComparison of multiple dietary non-digestible polysaccharides

Timeline

Start date
2012-08-01
Primary completion
2013-08-01
Completion
2014-06-01
First posted
2013-07-11
Last updated
2016-11-17

Source: ClinicalTrials.gov record NCT01896154. Inclusion in this directory is not an endorsement.